{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:45:12Z","timestamp":1790937912591,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ecl.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T07:01:06Z","timestamp":1687676466000},"page":"629-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Racial and Ethnic Disparities in Metabolic Bone Disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Lauren Y.","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linette","family":"Bosques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Cromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharl S.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine W.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri-Ann M.","family":"Burnett-Bowie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2023.05.004_bib1","series-title":"Unequal treatment: confronting racial and ethnic disparities in health care","article-title":"Committee on understanding and eliminating racial and ethnic disparities in health care","year":"2002"},{"key":"10.1016\/j.ecl.2023.05.004_bib2","unstructured":"Centers for Disease Control and Prevention. Leading Causes of Death in Females, United States. https:\/\/www.cdc.gov\/women\/lcod\/index.htm."},{"key":"10.1016\/j.ecl.2023.05.004_bib3","unstructured":"Centers for Disease Control and Prevention. Leading Causes of Death in Males, United States. https:\/\/www.cdc.gov\/minorityhealth\/lcod\/index.htm."},{"key":"10.1016\/j.ecl.2023.05.004_bib4","unstructured":"Centers for Disease Control and Prevention. Data and Statistics on Sickle Cell Disease. https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html#print."},{"key":"10.1016\/j.ecl.2023.05.004_bib5","unstructured":"Bryson S. UConn Team Awarded Nearly $3M to Study Bone Loss in Sickle Cell. 2023. https:\/\/sicklecellanemianews.com\/news\/bone-loss-scd-focus-nearly-3m-awarded-uconn-scientists\/."},{"issue":"12","key":"10.1016\/j.ecl.2023.05.004_bib6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-008-0634-y","article-title":"Incidence of fractures compared to cardiovascular disease and breast cancer: the Women's Health Initiative Observational Study","volume":"19","author":"Cauley","year":"2008","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.ecl.2023.05.004_bib7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporosis International"},{"issue":"24","key":"10.1016\/j.ecl.2023.05.004_bib8","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement","volume":"319","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ecl.2023.05.004_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.amjmed.2016.10.018","article-title":"Trends and Disparities in Osteoporosis Screening Among Women in the United States, 2008-2014","volume":"130","author":"Gillespie","year":"2017","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ecl.2023.05.004_bib10","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s11606-021-06938-8","article-title":"Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020","volume":"37","author":"Cromer","year":"2022","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ecl.2023.05.004_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2021.10.010","article-title":"Disparities in osteoporosis care among postmenopausal women in the United States","volume":"156","author":"Ruiz-Esteves","year":"2022","journal-title":"Maturitas"},{"issue":"12","key":"10.1016\/j.ecl.2023.05.004_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1089\/jwh.2012.3812","article-title":"Osteoporosis Healthcare Disparities in Postmenopausal Women","volume":"21","author":"Hamrick","year":"2012","journal-title":"J\u00a0Wom Health"},{"issue":"9","key":"10.1016\/j.ecl.2023.05.004_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1525-1497.2005.0157.x","article-title":"Disparities in osteoporosis screening between at-risk African-American and white women","volume":"20","author":"Miller","year":"2005","journal-title":"J\u00a0Gen Intern Med"},{"issue":"5","key":"10.1016\/j.ecl.2023.05.004_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.SMJ.0000053918.93363.B0","article-title":"Racial disparities in osteoporosis prevention in a managed care population","volume":"96","author":"Mudano","year":"2003","journal-title":"South Med J"},{"issue":"9","key":"10.1016\/j.ecl.2023.05.004_bib15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11606-007-0217-1","article-title":"Racial and Socioeconomic Disparities in Bone Density Testing Before and After Hip Fracture","volume":"22","author":"Neuner","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2023.05.004_bib16","first-page":"173","article-title":"Ethnic disparity in the treatment of women with established low bone mass","volume":"58","author":"Wei","year":"2003","journal-title":"J\u00a0Am Med Wom Assoc"},{"issue":"9","key":"10.1016\/j.ecl.2023.05.004_bib17","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00198-014-2747-9","article-title":"Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data","volume":"25","author":"Cunningham","year":"2014","journal-title":"Osteoporosis International"},{"issue":"11","key":"10.1016\/j.ecl.2023.05.004_bib18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1359\/jbmr.070713","article-title":"Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative","volume":"22","author":"Cauley","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2023.05.004_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejim.2019.04.011","article-title":"Disparities in osteoporosis by race\/ethnicity, education, work status, immigrant status, and economic status in the United States","volume":"64","author":"Tsai","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2023.05.004_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2105\/AJPH.80.3.326","article-title":"Sex-specific and race-specific hip fracture rates","volume":"80","author":"Kellie","year":"1990","journal-title":"Am J Publ Health"},{"issue":"8","key":"10.1016\/j.ecl.2023.05.004_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/gerona\/63.8.867","article-title":"The Association of Race, Gender, and Comorbidity With Mortality and Function After Hip Fracture","volume":"63","author":"Penrod","year":"2008","journal-title":"The journals of gerontology Series A, Biological sciences and medical sciences"},{"issue":"11","key":"10.1016\/j.ecl.2023.05.004_bib22","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/jgs.16785","article-title":"Bone Mineral Density in Older U.S. Filipino, Chinese, Japanese, and White Women","volume":"68","author":"Lo","year":"2020","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00198-011-1693-z","article-title":"Lumbar spine bone mineral density in US adults: demographic patterns and relationship with femur neck skeletal status","volume":"23","author":"Looker","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1359\/jbmr.090706","article-title":"Prevalence and Trends in Low Femur Bone Density Among Older US Adults: NHANES 2005\u20132006 Compared With NHANES III","volume":"25","author":"Looker","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.ecl.2023.05.004_bib25","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00198-018-4648-9","article-title":"Decreasing Trend of Bone Mineral Density in US Multiethnic Population: Analysis of Continuous NHANES 2005 - 2014","volume":"29","author":"Xu","year":"2018","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.ecl.2023.05.004_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bone.2012.08.118","article-title":"Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women","volume":"51","author":"Khandewal","year":"2012","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00198-012-2099-2","article-title":"The contributions of First Nations ethnicity, income, and delays in surgery on mortality post-fracture: a population-based analysis","volume":"24","author":"Leslie","year":"2013","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.ecl.2023.05.004_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","article-title":"The Association of Race\/Ethnicity and Risk of Atypical Femur Fracture among Older Women Receiving Oral Bisphosphonate Therapy","volume":"85","author":"Lo","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ecl.2023.05.004_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.afos.2017.03.001","article-title":"Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries","volume":"3","author":"Taguchi","year":"2017","journal-title":"Osteoporosis and Sarcopenia"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u2122 and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporosis International"},{"issue":"25","key":"10.1016\/j.ecl.2023.05.004_bib31","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture Prevention with Zoledronate in Older Women with Osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2023.05.004_bib32","series-title":"Cancer statistics data visualizations tool, based on 2021 submission data (1999-2019)","year":"2019"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat Med"},{"issue":"8 Suppl","key":"10.1016\/j.ecl.2023.05.004_bib34","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10428194.2017.1335398","article-title":"Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades","volume":"59","author":"Sun","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.ecl.2023.05.004_bib38","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib39","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jso.26765","article-title":"Sex, racial\/ethnic and socioeconomic disparities in patients with metastatic bone disease","volume":"125","author":"Jawad","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jso.27097","article-title":"Socioeconomic and insurance-related disparities in disease-specific survival among patients with metastatic bone disease","volume":"127","author":"Jawad","year":"2023","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/cncr.24087","article-title":"Racial disparities in the development of breast cancer metastases among older women: a multilevel study","volume":"115","author":"Schootman","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib42","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cam4.1322","article-title":"Racial\/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer","volume":"7","author":"Akinyemiju","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.ecl.2023.05.004_bib43","doi-asserted-by":"crossref","unstructured":"Zheng Z, Chen L, Lee JH, et al. Racial\/ethnic disparities in skeletal-related events among women treated with bisphosphonate therapy for bone metastasis secondary to breast cancer. Clin Oncol, 2018, 36(15_suppl), e13092-e13092.","DOI":"10.1200\/JCO.2018.36.15_suppl.e13092"},{"issue":"3","key":"10.1016\/j.ecl.2023.05.004_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/14737167.2015.1024662","article-title":"Racial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer","volume":"15","author":"Jayasekera","year":"2015","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"15","key":"10.1016\/j.ecl.2023.05.004_bib45","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.19.03148","article-title":"Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline","volume":"38","author":"Saylor","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ecl.2023.05.004_bib46","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1200\/OP.20.00479","article-title":"Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare","volume":"17","author":"Zhou","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ecl.2023.05.004_bib47","doi-asserted-by":"crossref","first-page":"101792","DOI":"10.1016\/j.canep.2020.101792","article-title":"Racial disparities in clinical presentation, type of intervention, and in-hospital outcomes of patients with metastatic spine disease: An analysis of 145,809 admissions in the United States","volume":"68","author":"De la Garza Ramos","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2023.05.004_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01402610","article-title":"Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression","volume":"107","author":"Bach","year":"1990","journal-title":"Acta Neurochir"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1377\/hlthaff.28.1.160","article-title":"A\u00a0matter of race: early-versus late-stage cancer diagnosis","volume":"28","author":"Virnig","year":"2009","journal-title":"Health Aff"},{"issue":"10","key":"10.1016\/j.ecl.2023.05.004_bib50","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/cncr.20276","article-title":"Patterns and predictors of colorectal cancer test use in the adult U.S. population","volume":"100","author":"Seeff","year":"2004","journal-title":"Cancer"},{"issue":"Suppl 20","key":"10.1016\/j.ecl.2023.05.004_bib51","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1097\/BRS.0000000000001827","article-title":"Predicting Neurologic Recovery after Surgery in Patients with Deficits Secondary to MESCC: Systematic Review","volume":"41","author":"Laufer","year":"2016","journal-title":"Spine"},{"key":"10.1016\/j.ecl.2023.05.004_bib52","series-title":"Spinal cord compression","author":"Singleton","year":"2022"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.ecl.2023.05.004_bib54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0033354919881438","article-title":"Reducing Health Care Disparities in Sickle Cell Disease: A Review","volume":"134","author":"Lee","year":"2019","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib55","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2141.2005.05476.x","article-title":"Bone involvement in sickle cell disease","volume":"129","author":"Almeida","year":"2005","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.ecl.2023.05.004_bib56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2023.05.004_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13936","article-title":"Racial and ethnic differences in sickle cell disease within the United States: From demographics to outcomes","author":"Pokhrel","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ecl.2023.05.004_bib58","series-title":"Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for hemoglobinopathies in newborns: reaffirmation update for the US preventive services task force","author":"Lin","year":"2007"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle Cell Disease: A Review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib60","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/15353702211068522","article-title":"Sickle cell disease as an accelerated aging syndrome","volume":"247","author":"Idris","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.ecl.2023.05.004_bib61","doi-asserted-by":"crossref","first-page":"e27503","DOI":"10.1002\/pbc.27503","article-title":"Risk of avascular necrosis of the femoral head in children with sickle cell disease on hydroxyurea: MRI evaluation","volume":"66","author":"Adekile","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.ecl.2023.05.004_bib62","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2106\/JBJS.E.01455","article-title":"The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease","volume":"88","author":"Hernigou","year":"2006","journal-title":"J\u00a0Bone Joint Surg"},{"issue":"21","key":"10.1016\/j.ecl.2023.05.004_bib63","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/hematology.2019000038","article-title":"Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management","volume":"2019","author":"Adesina","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.ecl.2023.05.004_bib65","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.1982.tb01887.x","article-title":"Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease","volume":"50","author":"Hawker","year":"1982","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ecl.2023.05.004_bib67","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.apmr.2005.01.008","article-title":"Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score","volume":"86","author":"Aguilar","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ecl.2023.05.004_bib68","unstructured":"University of Pennsylvannia. The University of Pennsylvania Classification of Osteonecrosis. https:\/\/radiologykey.com\/the-university-of-pennsylvania-classification-of-osteonecrosis\/."},{"issue":"10","key":"10.1016\/j.ecl.2023.05.004_bib69","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ecl.2023.05.004_bib70","first-page":"CD004344","article-title":"Treatment for avascular necrosis of bone in people with sickle cell disease","volume":"12","author":"Marti-Carvajal","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ecl.2023.05.004_bib71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.med.0000436192.25846.0b","article-title":"An update on the recent literature on sickle cell bone disease","volume":"20","author":"Osunkwo","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"10.1016\/j.ecl.2023.05.004_bib72","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/art.33498","article-title":"Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study","volume":"64","author":"Chen","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ecl.2023.05.004_bib73","first-page":"2155","article-title":"The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study","volume":"87","author":"Lai","year":"2005","journal-title":"J\u00a0Bone Joint Surg"},{"issue":"14","key":"10.1016\/j.ecl.2023.05.004_bib74","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2106\/JBJS.N.01157","article-title":"Does Zoledronate Prevent Femoral Head Collapse from Osteonecrosis? A Prospective, Randomized, Open-Label, Multicenter Study","volume":"97","author":"Lee","year":"2015","journal-title":"J\u00a0Bone Joint Surg"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12891-016-1379-y","article-title":"Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate","volume":"18","author":"Arai","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"10.1016\/j.ecl.2023.05.004_bib76","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00198-022-06455-2","article-title":"Sickle cell bone disease and response to intravenous bisphosphonates in children","volume":"33","author":"Grimbly","year":"2022","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib77","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/EJE-20-0299","article-title":"Osteogenesis imperfecta: an update on clinical features and therapies","volume":"183","author":"Marom","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ajh.20541","article-title":"High prevalence and correlates of low bone mineral density in young adults with sickle cell disease","volume":"81","author":"Miller","year":"2006","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.ecl.2023.05.004_bib79","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ecl.2023.05.004_bib80","first-page":"18","article-title":"Mechanisms of Bone Impairment in Sickle Bone Disease","author":"Giordano","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/nqz037","article-title":"Vitamin D status in the United States, 2011-2014","volume":"110","author":"Herrick","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib83","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.ecl.2023.05.004_bib84","doi-asserted-by":"crossref","first-page":"e0119908","DOI":"10.1371\/journal.pone.0119908","article-title":"Prevalence of vitamin D deficiency in sickle cell disease: a systematic review","volume":"10","author":"Nolan","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ecl.2023.05.004_bib85","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpeds.2004.06.055","article-title":"Low vitamin D status in children with sickle cell disease","volume":"145","author":"Buison","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"9","key":"10.1016\/j.ecl.2023.05.004_bib86","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jada.2008.06.433","article-title":"High risk of vitamin D deficiency in children with sickle cell disease","volume":"108","author":"Rovner","year":"2008","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"14","key":"10.1016\/j.ecl.2023.05.004_bib87","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2021.2227","article-title":"The USPSTF 2021 Recommendations on Screening for Asymptomatic Vitamin D Deficiency in Adults: The Challenge for Clinicians Continues","volume":"325","author":"Burnett-Bowie","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib88","first-page":"CD010858","article-title":"Vitamin D supplementation for sickle cell disease","volume":"1","author":"Soe","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ecl.2023.05.004_bib89","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bone.2012.10.005","article-title":"Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults","volume":"52","author":"Arlet","year":"2013","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.ecl.2023.05.004_bib90","article-title":"Development of algorithm for clinical management of sickle cell bone disease: evidence for a role of vertebral fractures in patient follow-up","volume":"9","author":"De Franceschi","year":"2020","journal-title":"J\u00a0Clin Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:50:17Z","timestamp":1760176217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852923000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0889852923000440"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2023.05.004","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and Ethnic Disparities in Metabolic Bone Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}